Multiplexed molecular diagnostics are generating great momentum across
an increasingly wide spectrum of investigations. Their promise of cost and labor
efficiencies and consumer-level ease of use is compelling.
Our latest report, 10 Inevitable Drivers of Molecular Diagnostics,
outlines why we believe this approach will soon dominate point-of-care, central
lab, and at-home testing for the foreseeable future.